DK195079A - Fremgangsmaade til fremstilling af stabile urokinaseinjektionspraeparater - Google Patents

Fremgangsmaade til fremstilling af stabile urokinaseinjektionspraeparater

Info

Publication number
DK195079A
DK195079A DK195079A DK195079A DK195079A DK 195079 A DK195079 A DK 195079A DK 195079 A DK195079 A DK 195079A DK 195079 A DK195079 A DK 195079A DK 195079 A DK195079 A DK 195079A
Authority
DK
Denmark
Prior art keywords
procedure
manufacture
stable
injection devices
urokinase injection
Prior art date
Application number
DK195079A
Other languages
English (en)
Other versions
DK147812B (da
Inventor
Y Yamahira
K Fujioka
Y Okuzawa
S Miura
S Sato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of DK195079A publication Critical patent/DK195079A/da
Publication of DK147812B publication Critical patent/DK147812B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK195079AA 1978-05-12 1979-05-10 Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat DK147812B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5682678 1978-05-12
JP5682678A JPS54147916A (en) 1978-05-12 1978-05-12 Preparation of urokinase injection

Publications (2)

Publication Number Publication Date
DK195079A true DK195079A (da) 1979-11-13
DK147812B DK147812B (da) 1984-12-17

Family

ID=13038173

Family Applications (1)

Application Number Title Priority Date Filing Date
DK195079AA DK147812B (da) 1978-05-12 1979-05-10 Fremgangsmaade til fremstilling af et stabilt lyofiliseret urokinasepraeparat

Country Status (10)

Country Link
US (1) US4244943A (da)
JP (1) JPS54147916A (da)
CA (1) CA1115206A (da)
CH (1) CH641046A5 (da)
DE (1) DE2917899A1 (da)
DK (1) DK147812B (da)
FR (1) FR2425245A1 (da)
GB (1) GB2021412B (da)
IT (1) IT7949032A0 (da)
SE (1) SE7904118L (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813521A (ja) * 1981-07-16 1983-01-26 Green Cross Corp:The ミエロペルオキシダ−ゼの粉末製剤
US4350659A (en) * 1981-07-30 1982-09-21 Corning Glass Works Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
JPS59139323A (ja) * 1983-01-28 1984-08-10 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
SU1128601A1 (ru) * 1983-05-10 1985-07-15 Всесоюзный кардиологический научный центр АМН СССР Урокиназа,иммобилизированна на фибриногене
JPS6051119A (ja) * 1983-08-30 1985-03-22 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS61111684A (ja) * 1984-11-05 1986-05-29 Terumo Corp 精製されたウロキナ−ゼ複合体の製造方法
JPS61124383A (ja) * 1984-11-16 1986-06-12 Unitika Ltd 固定化線維素溶解活性酵素の安定化法
DE3586952T2 (de) * 1985-01-14 1993-07-22 Shiseido Co Ltd Fibrinophiler urokinase-komplex und dessen herstellung.
JPS61238732A (ja) * 1985-04-16 1986-10-24 Green Cross Corp:The ウロキナーゼ前駆体乾燥製剤
CA1336585C (en) * 1985-04-16 1995-08-08 Kazuo Morimoto Method of stabilizing urokinase precursor and dry preparation containing said precursor
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
WO1990001334A1 (en) * 1988-08-05 1990-02-22 Codon Formulations for plasminogen activator using aspartate
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤
DE69025934T2 (de) * 1989-05-17 1996-09-19 Res Corp Technologies Inc Verfahren und zusammensetzung zur thrombosebehandlung beim säugetier
CA2020148C (en) * 1989-06-30 1995-07-11 Robert Angelo Mercuri Ultra-thin, pure flexible graphite
EP2236617A1 (en) 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
BR112012027361A2 (pt) 2010-04-27 2021-04-27 Scil Technology Gmbh formulação mia/cd-rap estável.
CN104906054B (zh) * 2015-06-15 2017-08-25 武汉人福药业有限责任公司 一种尿激酶冻干剂的制备方法
CN111450052A (zh) * 2020-04-22 2020-07-28 南京南大药业有限责任公司 一种尿激酶注射液制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (da) * 1963-12-23 1965-12-08
JPS5137343B2 (da) * 1972-12-07 1976-10-15

Also Published As

Publication number Publication date
CA1115206A (en) 1981-12-29
SE7904118L (sv) 1979-11-13
GB2021412B (en) 1982-08-25
JPS54147916A (en) 1979-11-19
DK147812B (da) 1984-12-17
CH641046A5 (de) 1984-02-15
GB2021412A (en) 1979-12-05
IT7949032A0 (it) 1979-05-11
US4244943A (en) 1981-01-13
DE2917899A1 (de) 1979-11-22
FR2425245A1 (fr) 1979-12-07
FR2425245B1 (da) 1983-03-11

Similar Documents

Publication Publication Date Title
DK195079A (da) Fremgangsmaade til fremstilling af stabile urokinaseinjektionspraeparater
DK197179A (da) Fremgangsmaade til fremstilling af glasvarer
DK428179A (da) Fremgangsmaade til fremstilling af metaboliter
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK37879A (da) Fremgangsmaade til fremstilling af oligoimider
DK146138C (da) Fremgangsmaade til fremstilling af stabile erythrocytpraeparater
DK20376A (da) Fremgangsmade til fremstilling af optisk aktive anthracyclinoner
DK1978A (da) Fremgangsmaade til fremstilling af en lerdue
DK212079A (da) Fremgangsmaade til fremstilling af urokinase
DK156253C (da) Fremgangsmaade til fremstilling af pyruvatoxidase
DK150984C (da) Fremgangsmaade til kontinuerlig fremstilling af azopigmenter
DK96380A (da) Fremgangsmaade til fremstilling af stabile injicerbare oploesninger af et oxytetracyclinchelatt
DK148259C (da) Fremgangsmaade til fremstilling af lysergolderivater
DK393379A (da) Fremgangsmaade til fremstilling af galeniske praeparater
DK154779A (da) Fremgangsmaade til epoxidation af lavere alfaolefiner
DK147266C (da) Fremgangsmaade til rensning af urokinase
DK156431C (da) Analogifremgangsmaade til fremstilling af n-substituerede 2-cyanaziridiner
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
DK369279A (da) Fremgangsmaade til fremstilling af gipsplader
DK154926C (da) Fremgangsmaade til fremstilling af en etomidatholdig infusionsvaeske
DK152752C (da) Fremgangsmaade til fremstilling af l-sulpirid
DK87079A (da) Fremgangsmaade til fremstilling af dialkylphospohorchloridothioter
DK1080A (da) Fremgangsmaade til fremstilling af aminer
DK424279A (da) Fremgangsmaade til fremstilling af formlegemer
DK532478A (da) Fremgangsmaade til fremstilling af cement

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons